Finance

Lists
Why is AFMDQ down 50.00%?
Dive Deeper
AFMDQ:OTCMKTS
Affimed NV
$0.00010
-50.00%
(-0.00010) 1D
Oct 20, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AFMDQ...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
3.04
Avg. vol.
15.44K
Volume
0.00
52-wk high
$0.05
52-wk low
$0.00
Beta
1.70
Shares outstanding
15.23M
No. of employees
76
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
3.04
Avg. vol.
15.44K
Volume
0.00
52-wk high
$0.05
52-wk low
$0.00
Beta
1.70
Shares outstanding
15.23M
No. of employees
76
News stories
From web sources and news partners
About Affimed NV
CEOShawn M. Leland
Employees76
FoundedJan 1, 2000
Headquarters-
SectorBiotechnology
Websiteaffimed.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Revenue
413.00K
155.00K
154.00K
164.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
10.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
4.31M
Operating expense
-
-
-
14.45M
Total operating expenses
-
-
-
14.45M
Operating income
-
-
-
-14.28M
Other non operating income
-
-
-
-58.00K
EBT including unusual items
-
-
-
-15.14M
EBT excluding unusual items
-
-
-
-15.14M
Income tax expense
-
-
-
1.00K
Effective tax rate
-
-
-
-0.01%
Other operating expenses
-
-
-
-
Net income
-
-
-
-15.14M
Net profit margin
-
-
-
-9,231.10%
Earnings per share
-6.52
-1.27
-1.01
-0.94
Interest and investment income
-
-
-
228.00K
Interest expense
-
-
-
-267.00K
Net interest expenses
-
-
-
-39.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-13.86M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps